Original release date: December 16, 2019
Access to this course expires on: August 25, 2022 at 11:59 PM Pacific Time
CME 1
Faculty: David S. Klimstra, MD
Learning Objectives:
- Distinguish hepatocellular adenoma from carcinoma based on biopsies.
- Understand the utility of hepatocyte markers in the diagnosis of hepatocellular carcinoma.
- Recognize methods to support a diagnosis of primary cholangiocarcinoma.
- Recognize the diagnostic utility and limitations of the HepPar-1 antibody.